Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - CAPITAL EXPENDITURES
Capital Expenditures OCX - OncoCyte Corporation
-281 K
LAST VALUE
64.64%
2 YEAR CAGR
-55.41%
5 YEAR CAGR
-27.37%
10 YEAR CAGR